Ask The Doctors: December 2018

New drugs called immune checkpoint inhibitors have revolutionized treatment for certain cancers, including melanoma and Hodgkin lymphoma. They are showing promise for other cancers as well. Examples of these drugs are pembrolizumab (Keytruda), atezolizumab (Tecentriq), ipilimumab (Yervoy) and nivolumab (Opdivo). These powerful drugs fight cancer by boosting the bodys own immune system. Cancer cells send out signals that block the ability of immune system cells to recognize and kill them. The new drugs inhibit these blocking signals, thus unleashing a stronger immune system response.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access